MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0005218
Infallible Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹106.73 Cr
▲ 3% YoY
Net profit · FY 2025
₹10.67 Lakh
Net margin 0.1%
EBITDA · FY 2025
₹3.37 Cr
EBITDA margin 3.2%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹2.44 Cr
Issued & subscribed
Open charges
₹36.95 Cr
Satisfied ₹8 Cr
Company age
7 yrs
Est. 2019
Employees · EPFO
69
Provident fund records
About Infallible Pharma Private Limited
Data last updated:
Infallible Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2019PTC322834. Its GSTIN is 27AAFCI2186P1ZZ (Maharashtra). The company holds 5 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.44 Cr. It is led by directors including Hari Om (Managing Director) and Shreekant Krishna Shetty (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 202 2nd Floor Matru Smruti Building Lokmanylak Road No. 02 Dadar East, Mumbai, Maharashtra, India – 400014.
As per the financials filed for FY 2025, the company reported a revenue of ₹106.73 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹10.67 Lakh (net margin 0.1%) and EBITDA of ₹3.37 Cr (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 111% over five years.
The company has about 69 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Infallible Pharma. As per MCA filings, the company has open charges of ₹36.95 Cr and satisfied charges of ₹8 Cr on record. Court records list 21 cases involving the company, including 12 filed by the company and 9 filed against it; 8 cases are pending. The company has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹4.99 Cr; the latest was in November 2021. Its 10 peer companies in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Anugrah Inorg Private Limited with revenue of ₹107 Cr.
Infallible Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0005218). For more details, the company can be reached via its website infalliblepharma.com.
Company details
CIN U24304MH2019PTC322834
Registration Number 322834
Incorporation Date 20 March 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0005218
Key People
Hari Om Managing Director Shreekant Krishna Shetty Whole-Time Director Hari Krishnababu Naidu Director Recognitions & Rankings of Infallible Pharma
Contact details
Infallible Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is infalliblepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address202 2nd Floor Matru Smruti Building Lokmanylak Road No. 02 Dadar East, Mumbai, Maharashtra, India – 400014
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Infallible Pharma Private Limited, buy the company report.
Comprehensive company report
Infallible Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Infallible Pharma operates one associated brand: Infallible Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| R&D company manufacturing drugs for multiple therapeutic areas | infalliblepharma.com |
Business activity
The main business activity of Infallible Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Infallible Pharma Private Limited, buy the company report.
Financials of Infallible Pharma Private Limited
FY 2025 filings availableInfallible Pharma Private Limited reported revenue of ₹106.73 Cr (up 3% YoY) for FY 2025.
Revenue · FY 2025
₹106.73 Cr ▲ 3%
Net profit · FY 2025
₹10.67 Lakh margin 0.1%
EBITDA · FY 2025
₹3.37 Cr margin 3.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▼ 9%
5 years · compounded
▲ 111%
EBITDA CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 29%
5 years · compounded
▲ 282%
Revenue has grown at a compounded annual rate (CAGR) of 111% over five years, including 3% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.37 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.67 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Infallible Pharma Private Limited, buy the company report.
Board of directors of Infallible Pharma Private Limited
Infallible Pharma has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shreekant Krishna Shetty Also directs: Mckesson & Robbins Private Limited, Amerisourcebergen Private Limited, Sagent Pharmaceuticals Private Limited and 2 more | Whole-Time Director | 01 Sep 2019 | 7 Years 2 Months | Current |
| Hari Om Also directs: Mckesson & Robbins Private Limited, Amerisourcebergen Private Limited, Sagent Pharmaceuticals Private Limited and 3 more | Managing Director | 20 Mar 2019 | 7 Years 7 Months | Current |
| Hari Krishnababu Naidu | Director | 16 Dec 2024 | 1 Years 10 Months | Current |
Peer comparison
Infallible Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anugrah Inorg Private Limited | ₹107 Cr (FY 2025) | 92.0% | Vadodara, Gujarat, India | |||
| Yogi Intermediates Private Limited | ₹106.98 Cr (FY 2025) | 13.0% | Ahmedabad, Gujarat, India | |||
| Robertet India Private Limited | ₹106.94 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Auchtel Products Limited | ₹106.86 Cr (FY 2025) | -4.0% | Mumbai, Maharashtra, India | |||
| Mepco Industries Limited | ₹106.77 Cr (FY 2025) | -1.0% | Madurai, Tamil Nadu, India | |||
| Infallible Pharma Private Limitedthis company | ₹106.73 Cr (FY 2025) | ₹10.67 Lakh | 0.1% | 3.0% | 69 | Mumbai, Maharashtra, India |
| L S R Speciality Oils Private Limited | ₹106.73 Cr (FY 2025) | -28.0% | Mumbai, Maharashtra, India | |||
| Netmatrix Crop Care Private Limited | ₹106.6 Cr (FY 2025) | 20.0% | Hyderabad, Telangana, India | |||
| Gulshan Chemicals Private Limited | ₹106.58 Cr (FY 2025) | -11.0% | New Delhi, Delhi, India | |||
| Swastik Pesticides Limited | ₹106.54 Cr (FY 2025) | 3.0% | New Delhi, Delhi, India | |||
| Myk Laticrete Private Limited | ₹106.54 Cr (FY 2025) | 979.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Infallible Pharma Private Limited, buy the company report.
Auditor
Infallible Pharma Private Limited is audited by ROHIT J VISHWAKARMA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ROHIT J VISHWAKARMA | FY 2023 | 166480 |
Shareholding
The shareholding of Infallible Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Infallible Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹36.95 Cr
Satisfied charges
₹8 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Aug 2024 | 100972638 | Others | ₹8 Cr | Open | |
| 24 Nov 2023 | 100829638 | Others | ₹7.5 Cr | Open | |
| 26 Aug 2021 | 100510121 | Others | ₹21.45 Cr | Open | |
| 27 Oct 2022 | 100629400 | Others | ₹8 Cr | Satisfied |
To see the full charge records of Infallible Pharma Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Infallible Pharma Private Limited has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹4.99 Cr; the latest was in November 2021.
Total deals
4
Funding rounds
2
Secondary share transfers
2
Disclosed funding
₹4.99 Cr
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2021 | Funding round | ₹3 Cr | Investors: 2 individuals |
| Mar 2021 | Funding round | ₹1.99 Cr | Investors: an individual |
| Feb 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Oct 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Infallible Pharma Private Limited has 21 court cases on record: 12 filed by Infallible Pharma, 9 filed against it. 8 cases are pending and 13 are disposed.
Total cases
21
Filed by the company
12
Filed against the company
9
Pending
8
Disposed
13
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 14 | 4 | 2 |
| District courts | 6 | 4 | 5 |
| Supreme Court | 1 | 1 | 1 |
Cases on record (5 of 21)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed against the company by Stanex Drugs and Chemicals Pvt. Limited | Pending |
| High Court of Himachal Pradesh | Court case (OMP) | Filed by the company against Canara Bank and Others | Disposed |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Makcur Laboratories Ltd. - Brijesh Dhirajlal Patel | Disposed |
| High Court | Interim or miscellaneous application | Filed by the company against Canara Bank Ltd and Ors(Not Applicable) | Disposed |
| High Court, HIMACHAL PRADESH | Writ petition | Filed by the company against Canara Bank Ltd and Ors(Not Applicable) | Disposed |
To see the full case history of Infallible Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Infallible Pharma Private Limited was last rated by Icra on 10 Aug 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 10 Aug 2021 |
To see the full credit ratings and regulatory alerts of Infallible Pharma Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Infallible Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Infallible Pharma Private Limited has a workforce of 69 employees on its EPFO records as of Mar 23, 2024, across 1 active EPFO establishment.
Employee count
69
Active EPFO establishments
1
Employee growth
2.99%
GST
Infallible Pharma has 5 GST registrations: 2 active and 3 cancelled or inactive.
Total GSTINs
5
Active
2
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCI2186P1ZZ | Maharashtra | Active | 23 May 2019 |
| 02AAFCI2186P1ZB | Himachal Pradesh | Active | 04 Oct 2022 |
To see the full GST registrations and return filing status of Infallible Pharma Private Limited, buy the company report.
Recent activity
Infallible Pharma Private Limited has 10 board changes on record since 2019: 3 appointments and 7 cessations. The latest: Hari Krishnababu Naidu ceased to be Additional Director on 29 Sep 2025.
AGM
Infallible Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Hari Krishnababu Naidu ceased to be Additional Director.
Filing
Infallible Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Hari Krishnababu Naidu was appointed as Director.
Charges
A charge with Others amounted to Rs. 8.00 Cr with Charge ID 100972638 was registered on 21 Aug 2024.
Charges
A charge with Others of Rs. 21.45 Cr registered on 26 Aug 2021 with Charge ID 100510121 was modified on 21 Aug 2024.
Charges
A charge with Others amounted to Rs. 7.50 Cr with Charge ID 100829638 was registered on 24 Nov 2023.
Charges
A charge registered on 27 Oct 2022 via Charge ID 100629400 with Others was fully satisfied on 07 Sep 2023.
Charges
A charge with Others amounted to Rs. 8.00 Cr with Charge ID 100629400 was registered on 27 Oct 2022.
Ceased
Devidas Balkrishna Bhatlawande ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 21.45 Cr with Charge ID 100510121 was registered on 26 Aug 2021.
Ceased
Hari Om ceased to be Director.
7 earlier events are in the company report.
Frequently asked questions
Infallible Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 March 2019 (7+ years old) and is registered under CIN U24304MH2019PTC322834.
Infallible Pharma has 3 current directors:
- Hari Om - Managing Director
- Shreekant Krishna Shetty - Whole-Time Director
- Hari Krishnababu Naidu - Director
The latest financial statements of Infallible Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Infallible Pharma is 27AAFCI2186P1ZZ, registered in Maharashtra. The company has 5 GST registrations in all, of which 2 are active and 3 are cancelled or inactive. Other active GSTINs include 02AAFCI2186P1ZB (Himachal Pradesh).
The CIN (Corporate Identification Number) of Infallible Pharma is U24304MH2019PTC322834. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Infallible Pharma has 21 court cases on record: 12 filed by the company and 9 filed against it. 8 are pending. Most are in the high courts.
Infallible Pharma was incorporated on 20 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Infallible Pharma has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹4.99 Cr; the latest was in November 2021.
The peers of Infallible Pharma by revenue are Anugrah Inorg Private Limited, Yogi Intermediates Private Limited, Robertet India Private Limited, Auchtel Products Limited, Mepco Industries Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Hari Krishnababu Naidu ceased to be Additional Director on 29 Sep 2025. Hari Krishnababu Naidu was appointed as Director on 16 Dec 2024. Devidas Balkrishna Bhatlawande ceased to be Additional Director on 07 Jul 2022. Infallible Pharma has 10 board changes on record in total.
Yes, Infallible Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0005218).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages